The Cell-based Assays Market is a segment of the pharmaceutical and biotechnology industries that involves the use of living cells to study cellular functions, drug responses, toxicity levels, and other biological activities. These assays play a crucial role in drug discovery, development, and safety testing. They are used to assess the effects of pharmaceutical compounds on cells and to predict their behavior in the human body. The market's growth is attributed to the increasing demand for targeted and personalized medicines, advancements in cell culture technologies, and a growing focus on precision medicine.
According to the new market research report "Cell based Assays Market by Product & Service (Reagents, Assays Kits, Cell Lines, Microplates, Probes & Labels, Instruments & Software), Application (Drug Discovery (Toxicity, Pharmacokinetics), Research), End User (CROS, Pharma) & Region - Global Forecast to 2028"
The global cell based assays market in terms of revenue was estimated to be worth $18.9 billion in 2023 and is poised to reach $28.2 billion by 2028, growing at a CAGR of 8.4% from 2023 to 2028.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=119917269
DRIVER: Growing demand for drug discovery & development and increasing preference for cell-based assays in drug discovery
The growing demand for drug discovery & development is a major factor driving growth in the cell-based assays market. Cell-based assays play a crucial role in early-stage drug screening by providing valuable insights into the efficacy, safety, and potential side-effects of drug candidates. Researchers can use these assays to assess how drugs interact with cellular targets, enabling the identification of promising compounds for further drug development. This approach offers a cost-effective and time-efficient alternative to animal models, reducing the need for extensive preclinical testing.
Market key Players
Key players in the cell based assays market include Danaher Corporation (US), Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), Becton, Dickinson and Company (US), Lonza (Switzerland), PerkinElmer (US), Charles River Laboratories (US), Eurofins Scientific (France), Enzo Biochem (US), Carna Biosciences (Japan), Cell Biolabs (US), Promega Corporation (US), Cell Signaling Technology (US), BioAgilytix Labs (US), Reaction Biology Corporation (US), AAT Bioquest (US), Pestka Biomedical Laboratories (US), InvivoGen (US), CA3 Biosciences (US), BPS Bioscience (US), BellBrook Labs (US), Profacgen (US), BMG LABTECH (Germany), Hanugen Therapeutics (India), and JRS Pharma (Germany).
Report Objectives
- To provide detailed information regarding the major factors (such as drivers, restraints, opportunities, and challenges) influencing the market growth
- To strategically analyze micro markets with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To strategically analyze the market structure and profile the key players of the market and comprehensively analyze their core competencies
- To forecast the size of the market segments with respect to four regions, namely, North America, Europe, Asia Pacific, and the Rest of the World (Latin America and the Middle East & Africa)
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs.
Get 10% Free Customization on this Report-https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=119917269
About MarketsandMarkets™:
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines — TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies -helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, and facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn, and Facebook.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1–888–600–6441
Email:
